These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 12480292)
1. Atovaquone-loaded nanocapsules: influence of the nature of the polymer on their in vitro characteristics. Cauchetier E; Deniau M; Fessi H; Astier A; Paul M Int J Pharm; 2003 Jan; 250(1):273-81. PubMed ID: 12480292 [TBL] [Abstract][Full Text] [Related]
2. Entrapment efficiency and initial release of phenylbutazone from nanocapsules prepared from different polyesters. Marchais H; Benali S; Irache JM; Tharasse-Bloch C; Lafont O; Orecchioni AM Drug Dev Ind Pharm; 1998 Sep; 24(9):883-8. PubMed ID: 9876542 [TBL] [Abstract][Full Text] [Related]
3. Nanomedicine I: In vitro and in vivo evaluation of paclitaxel loaded poly-(ε-caprolactone), poly (DL-lactide-co-glycolide) and poly (DL-lactic acid) matrix nanoparticles in wistar rats. VasanthaKumar S; Ahamed HN; Saha RN Eur J Drug Metab Pharmacokinet; 2015 Jun; 40(2):137-61. PubMed ID: 24671895 [TBL] [Abstract][Full Text] [Related]
4. Gentamicin encapsulation in PLA/PLGA microspheres in view of treating Brucella infections. Prior S; Gamazo C; Irache JM; Merkle HP; Gander B Int J Pharm; 2000 Feb; 196(1):115-25. PubMed ID: 10675713 [TBL] [Abstract][Full Text] [Related]
5. Stability of insulin during the erosion of poly(lactic acid) and poly(lactic-co-glycolic acid) microspheres. Ibrahim MA; Ismail A; Fetouh MI; Göpferich A J Control Release; 2005 Sep; 106(3):241-52. PubMed ID: 15970349 [TBL] [Abstract][Full Text] [Related]
6. Development and evaluation of novel biodegradable microspheres based on poly(d,l-lactide-co-glycolide) and poly(epsilon-caprolactone) for controlled delivery of doxycycline in the treatment of human periodontal pocket: in vitro and in vivo studies. Mundargi RC; Srirangarajan S; Agnihotri SA; Patil SA; Ravindra S; Setty SB; Aminabhavi TM J Control Release; 2007 May; 119(1):59-68. PubMed ID: 17331611 [TBL] [Abstract][Full Text] [Related]
7. Design of triptorelin loaded nanospheres for transdermal iontophoretic administration. Nicoli S; Santi P; Couvreur P; Couarraze G; Colombo P; Fattal E Int J Pharm; 2001 Feb; 214(1-2):31-5. PubMed ID: 11282233 [TBL] [Abstract][Full Text] [Related]
8. Formulation of L-asparaginase-loaded poly(lactide-co-glycolide) nanoparticles: influence of polymer properties on enzyme loading, activity and in vitro release. Gasper MM; Blanco D; Cruz ME; Alonso MJ J Control Release; 1998 Mar; 52(1-2):53-62. PubMed ID: 9685935 [TBL] [Abstract][Full Text] [Related]
9. Stability study of nanoparticles of poly(epsilon-caprolactone), poly(D,L-lactide) and poly(D,L-lactide-co-glycolide). Lemoine D; Francois C; Kedzierewicz F; Preat V; Hoffman M; Maincent P Biomaterials; 1996 Nov; 17(22):2191-7. PubMed ID: 8922605 [TBL] [Abstract][Full Text] [Related]
10. Assessment of the activity of atovaquone-loaded nanocapsules in the treatment of acute and chronic murine toxoplasmosis. Sordet F; Aumjaud Y; Fessi H; Derouin F Parasite; 1998 Sep; 5(3):223-9. PubMed ID: 9772721 [TBL] [Abstract][Full Text] [Related]
11. Nanoparticle-based topical ophthalmic formulation for sustained release of stereoisomeric dipeptide prodrugs of ganciclovir. Yang X; Shah SJ; Wang Z; Agrahari V; Pal D; Mitra AK Drug Deliv; 2016 Sep; 23(7):2399-2409. PubMed ID: 25564964 [TBL] [Abstract][Full Text] [Related]
12. Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterisation and in vivo evaluation. Redhead HM; Davis SS; Illum L J Control Release; 2001 Feb; 70(3):353-63. PubMed ID: 11182205 [TBL] [Abstract][Full Text] [Related]
13. Preparation, characterization, cytotoxicity and transfection efficiency of poly(DL-lactide-co-glycolide) and poly(DL-lactic acid) cationic nanoparticles for controlled delivery of plasmid DNA. Basarkar A; Devineni D; Palaniappan R; Singh J Int J Pharm; 2007 Oct; 343(1-2):247-54. PubMed ID: 17611054 [TBL] [Abstract][Full Text] [Related]
14. Preparation, purification and morphology of polymeric nanoparticles as drug carriers. Venier-Julienne MC; Benoît JP Pharm Acta Helv; 1996 Jul; 71(2):121-8. PubMed ID: 8810578 [TBL] [Abstract][Full Text] [Related]
15. Poly(lactic-co-glycolic acid) microspheres for the controlled release of huperzine A: in vitro and in vivo studies and the application in the treatment of the impaired memory of mice. Chu D; Tian J; Liu W; Li Z; Li Y Chem Pharm Bull (Tokyo); 2007 Apr; 55(4):625-8. PubMed ID: 17409558 [TBL] [Abstract][Full Text] [Related]
16. Salmon calcitonin-loaded Eudragit® and Eudragit®-PLGA nanoparticles: in vitro and in vivo evaluation. Cetin M; Aktas MS; Vural I; Ozturk M J Microencapsul; 2012; 29(2):156-66. PubMed ID: 22126314 [TBL] [Abstract][Full Text] [Related]
17. Physicochemical characterization of poly(L-lactic acid) and poly(D,L-lactide-co-glycolide) nanoparticles with polyethylenimine as gene delivery carrier. Kim IS; Lee SK; Park YM; Lee YB; Shin SC; Lee KC; Oh IJ Int J Pharm; 2005 Jul; 298(1):255-62. PubMed ID: 15941631 [TBL] [Abstract][Full Text] [Related]
18. Optimization of the encapsulation and release of beta-lactoglobulin entrapped poly(DL-lactide-co-glycolide) microspheres. Rojas J; Pinto-Alphandary H; Leo E; Pecquet S; Couvreur P; Fattal E Int J Pharm; 1999 Jun; 183(1):67-71. PubMed ID: 10361157 [TBL] [Abstract][Full Text] [Related]
19. Poly(vinyl alcohol)-graft-poly(lactide-co-glycolide) nanoparticles for local delivery of paclitaxel for restenosis treatment. Westedt U; Kalinowski M; Wittmar M; Merdan T; Unger F; Fuchs J; Schäller S; Bakowsky U; Kissel T J Control Release; 2007 May; 119(1):41-51. PubMed ID: 17346845 [TBL] [Abstract][Full Text] [Related]
20. The stability and immunogenicity of a protein antigen encapsulated in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol. Lavelle EC; Yeh MK; Coombes AG; Davis SS Vaccine; 1999 Feb; 17(6):512-29. PubMed ID: 10075157 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]